ACTRIIA-Fc Rebalances BMP and Activin/TGF-β Signaling to Attenuate Experimental Pulmonary Hypertension

被引：0
|
作者：
Yung, L. [1 ]
Yang, P. [1 ]
Bocobo, G. [1 ]
Dinter, T. [1 ]
Pearsall, S. [2 ]
Sako, D. [2 ]
Kumar, R. [2 ]
Yu, P. B. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[2] Acceleron Pharma, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7399
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ActRIIA-Fc Rebalances Activin/GDF and BMP9 Signaling to Attenuate Experimental Pulmonary Hypertension
    Yung, Lai-Ming
    Yang, Peiran
    Bocobo, Geoffrey
    Dinter, Teresa
    McNeil, Megan
    Chen, Po-Sheng
    Southwood, Mark
    Morrell, Nicholas
    Pearsall, Scott
    Joshi, Sachindra
    Sako, Dianne
    Li, Gang
    Kumar, Ravindra
    Yu, Paul
    CIRCULATION, 2018, 138
  • [2] ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
    Yung, Lai-Ming
    Yang, Peiran
    Joshi, Sachindra
    Augur, Zachary M.
    Kim, Stephanie S. J.
    Bocobo, Geoffrey A.
    Dinter, Teresa
    Troncone, Luca
    Chen, Po-Sheng
    McNeil, Megan E.
    Southwood, Mark
    de Frias, Sergio Poli
    Knopf, John
    Rosas, Ivan O.
    Sako, Dianne
    Pearsall, R. Scott
    Quisel, John D.
    Li, Gang
    Kumar, Ravindra
    Yu, Paul B.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (543)
  • [3] ACTRIIA-Fc (Sotatercept) Reverses Pulmonary Vascular Remodeling to Attenuate Pulmonary Arterial Hypertension (PAH) by Rebalancing TGF-b/BMP Signaling in a Preclinical Model
    Joshi, S. R.
    Liu, J.
    Pearsall, R. S.
    Li, G.
    Kumar, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [4] Mediator 1 Regulation Of The BMP/TGF-β Signaling In Endothelium: Implications For Pulmonary Hypertension
    Wang, Chen
    Xing, Yuanming
    Zhang, Jiao
    He, Ming
    Yuan, Zuyi
    Yuan, Jason X. -J.
    Shyy, John Y.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42
  • [5] An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension
    Upton, Paul D.
    Dunmore, Benjamin J.
    Li, Wei
    Morrell, Nicholas W.
    DEVELOPMENTAL DYNAMICS, 2023, 252 (03) : 327 - 342
  • [6] Pulmonary Arterial Hypertension and TGF-β Superfamily Signaling: Focus on Sotatercept
    Stump, Benjamin
    Waxman, Aaron B.
    BIODRUGS, 2024, 38 (06) : 743 - 753
  • [7] Targeting the TGF-β signaling pathway for resolution of pulmonary arterial hypertension
    Sharmin, Nahid
    Nganwuchu, Chinyere Chioma
    Nasim, Md Talat
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2021, 42 (07) : 510 - 513
  • [8] MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension
    Wang, Chen
    Xing, Yuanming
    Zhang, Jiao
    He, Ming
    Dong, Jianjie
    Chen, Shanshan
    Wu, Haoyu
    Huang, Hsi-Yuan
    Chou, Chih-Hung
    Bai, Liang
    He, Fangzhou
    She, Jianqing
    Su, Ailing
    Wang, Youhua
    Thistlethwaite, Patricia A.
    Huang, Hsien-Da
    Yuan, Jason X-J
    Yuan, Zu-Yi
    Shyy, John Y-J
    CIRCULATION RESEARCH, 2022, 131 (10) : 828 - 841
  • [9] BMP-3 Promotes Mesenchymal Stem Cell Proliferation Through the TGF-β/Activin Signaling Pathway
    Stewart, Aaron
    Guan, Haiyan
    Yang, Kaiping
    JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 223 (03) : 658 - 666
  • [10] A Switch in TGF-β Signaling Explains Contradictory Findings in Pulmonary Arterial Hypertension
    Farkas, Laszlo
    Kolb, Martin R. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (02) : 157 - 159
12345